Your search returned 277 results.

Results
	161.	Variation in analytic transparency in recent efficacy studies of antidepressant medication. [electronic resource] by Vannoy, Steven Brodt, Madeline Cosgrove, Lisa Shaughnessy, Allen F Producer: 20190325 In: BMJ evidence-based medicine vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	162.	Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. [electronic resource] by Soini, Erkki Hallinen, Taru Brignone, Mélanie Campbell, Rosanne Diamand, Françoise Cure, Sandrine Aalto-Setälä, Maria Danchenko, Natalya Koponen, Hannu Kolasa, Katarzyna Producer: 20170804 In: Expert review of pharmacoeconomics & outcomes research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	163.	A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction. [electronic resource] by Keefe, Richard S E Nomikos, George Zhong, Wei Christensen, Michael Cronquist Jacobson, William Producer: 20190501 In: The international journal of neuropsychopharmacology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	164.	Vortioxetine treatment for generalised anxiety disorder: a meta-analysis of anxiety, quality of life and safety outcomes. [electronic resource] by Qin, Bin Huang, Guangsu Yang, Qian Zhao, Mingjun Chen, Hong Gao, Wen Yang, Mingxiu Producer: 20201201 In: BMJ open vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	165.	Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain. [electronic resource] by Yang, Kai-Chun Stepanov, Vladimir Amini, Nahid Martinsson, Stefan Takano, Akihiro Bundgaard, Christoffer Bang-Andersen, Benny Sanchez, Connie Halldin, Christer Farde, Lars Finnema, Sjoerd J Producer: 20200316 In: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	166.	Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI). [electronic resource] by McIntyre, Roger S Lee, Yena Producer: 20160718 In: Current opinion in psychiatry vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	167.	Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats. [electronic resource] by Lu, Yanxia Ho, Cyrus S McIntyre, Roger S Wang, Wei Ho, Roger C Producer: 20190726 In: Brain research bulletin vol. 142 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	168.	Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder. [electronic resource] by Sobreira, Gonçalo Oliveira, João Brissos, Sofia Producer: 20171204 In: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	169.	Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial. [electronic resource] by Inoue, Takeshi Nishimura, Akira Sasai, Kiyofumi Kitagawa, Tadayuki Producer: 20180824 In: Psychiatry and clinical neurosciences vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	170.	The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram. [electronic resource] by Vieta, Eduard Sluth, Lasse B Olsen, Christina K Producer: 20180906 In: Journal of affective disorders vol. 227 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	171.	Antidepressants and their effect on cognition in major depressive disorder. [electronic resource] by Papakostas, George I Producer: 20151203 In: The Journal of clinical psychiatry vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	172.	Vortioxetine overdose in a suicidal attempt: A case report. [electronic resource] by Mazza, Mario Gennaro Rossetti, Aurora Botti, Eugenia Rossana Clerici, Massimo Producer: 20180709 In: Medicine vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	173.	Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. [electronic resource] by Rothschild, Anthony J Mahableshwarkar, Atul R Jacobsen, Paula Yan, Mingjin Sheehan, David V Producer: 20130826 In: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	174.	Drug interactions with vortioxetine, a new multimodal antidepressant. [electronic resource] by Spina, Edoardo Santoro, Vincenza Producer: 20170321 In: Rivista di psichiatria vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	175.	The effect of vortioxetine on overall patient functioning in patients with major depressive disorder. [electronic resource] by Florea, Ioana Loft, Henrik Danchenko, Natalya Rive, Benoît Brignone, Melanie Merikle, Elizabeth Jacobsen, Paula L Sheehan, David V Producer: 20171030 In: Brain and behavior vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	176.	The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine. [electronic resource] by François, Clément Nielsen, Rebecca Danchenko, Natalya Williams, Valerie Lançon, Christophe Producer: 20180103 In: Current medical research and opinion vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	177.	Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome. [electronic resource] by Christensen, Michael Cronquist Munro, Vicki Producer: 20190701 In: Current medical research and opinion vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	178.	A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder. [electronic resource] by Jain, Rakesh Mahableshwarkar, Atul R Jacobsen, Paula L Chen, Yinzhong Thase, Michael E Producer: 20130821 In: The international journal of neuropsychopharmacology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	179.	Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial. [electronic resource] by Cao, Bing Park, Caroline Rosenblat, Joshua D Chen, Yan Iacobucci, Michelle Subramaniapillai, Mehala Mansur, Rodrigo B Zuckerman, Hannah Lee, Yena McIntyre, Roger S Producer: 20200723 In: Journal of psychopharmacology (Oxford, England) vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	180.	Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder. [electronic resource] by Baldwin, David S Loft, Henrik Florea, Ioana Producer: 20120927 In: International clinical psychopharmacology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 277 results.